Glucosalino Hiposódico

Glucosalino Hiposódico is an intravenous solution that contains sodium chloride and glucose as its active ingredients. It is supplied in a sterile liquid form for parenteral administration, without a specified concentration on the label. The product is classified as a fluid and electrolyte replenisher and is marketed in the European Union. It requires a prescription and is used under medical supervision for fluid and electrolyte management.

Glucosalino Hiposódico is indicated for clinical situations where intravenous fluid replacement and electrolyte balance are required. It is commonly employed in the following contexts:

- Perioperative hydration to maintain intravascular volume during surgery. - Treatment of mild to moderate dehydration from gastrointestinal losses. - Management of hypoglycemia by providing an immediate glucose source. - Electrolyte correction in patients with sodium chloride deficits. - Supportive therapy for patients unable to tolerate oral intake. - Fluid resuscitation in trauma patients with blood loss. - Adjunctive therapy during dialysis to prevent hypotension.

The intravenous administration of Glucosalino Hiposódico may be associated with a range of adverse reactions. Most events are mild and transient, while rare serious effects require medical attention. The frequency and severity of these events depend on patient condition, infusion rate, and total volume administered.

Common: - Local irritation or pain at the infusion site. - Mild hypernatremia manifested by transient thirst. - Transient increase in blood glucose levels. - Mild electrolyte imbalance such as slight hypokalemia. - Mild metabolic acidosis due to infusion of chloride. - Transient increase in urine output (diuresis).

Serious: - Severe hypernatremia leading to neurological symptoms. - Allergic reactions including rash, urticaria, or anaphylaxis. - Fluid overload causing pulmonary edema, especially in patients with cardiac dysfunction.

When using Glucosalino Hiposódico, clinicians should evaluate patient-specific factors and monitor for potential complications. Appropriate precautions help minimize risks associated with intravenous fluid therapy.

- Assess serum electrolytes and glucose before initiating therapy. - Adjust infusion rate in patients with cardiac or renal impairment. - Avoid rapid administration in individuals at risk for cerebral edema. - Monitor fluid balance and signs of overload during treatment. - Use caution in patients with known hypersensitivity to sodium chloride or glucose solutions. - Re-evaluate therapy regularly in neonates and elderly patients.

Glucosalino Hiposódico may interact with other intravenous solutions or medications that affect fluid and electrolyte balance. Consider the following interaction categories when planning therapy.

Avoid: - Co-administration with hypertonic saline solutions that could cause severe hypernatremia. - Simultaneous infusion of large volumes of dextrose-containing fluids in patients at risk for hyperglycemia.

Use with caution: - Concurrent use of diuretics, which may amplify electrolyte shifts. - Administration alongside nephrotoxic drugs, requiring close monitoring of renal function. - Combination with blood products, as rapid volume changes can affect hemodynamics. - Concurrent use with vasopressors may require adjustment of infusion rate to maintain target blood pressure.